MBLAC1 and metabolic syndrome: Our findings of altered glucose and cholesterol homeostasis, along with changes in heart mass, suggest the presence of a metabolic syndrome that may drive the cardiovascular dysfunction associated with AD who demonstrate reduced MBLAC1 expression.